Acute severe ulcerative colitis (ASUC) occurs in up to 25% of patients with ulcerative colitis
(UC). Therapeutic approaches have evolved during the past years with the increasing bio …

Acute Severe Ulcerative Colitis (ASUC) is a severe form of ulcerative colitis relapse which
requires hospitalization and intensive medical intervention to avoid colectomy. The timely …

METHODS: This single-center, double-blind, placebo-controlled trial randomized adult
patients with ASUC (defined by the Truelove Witts severity criteria) to receive either …

Acute severe ulcerative colitis (ASUC) is a distinctive ulcerative colitis flare presentation
characterised by the presence of systemic inflammation as well as bloody diarrhoea, and …

Indeterminate colitis (IC) is described in approximately 5–15% of patients with inflammatory
bowel disease (IBD). It usually reflects a difficulty or lack of clarity in distinguishing between …

Background and aims: Intravenous corticosteroids (IVCS) and rescue therapy with infliximab
(IFX) are useful for managing patients with acute severe ulcerative colitis (ASUC). However …

Background: Cyclosporine is a rescue treatment alternative to avoid colectomy in
corticosteroid refractory acute severe ulcerative colitis. In this study, we aimed to evaluate …

Acute severe colitis is a severe complication of ulcerative colitis, affecting approximately
20% of patients. For physicians, it remains a challenging condition to treat. Current treatment …

Abstract Background In 2014, infliximab (IFX) was listed on the Australian Pharmaceutical
Benefits Scheme for acute severe ulcerative colitis (ASUC) and is now the preferred option …

Acute severe ulcerative colitis is a medical emergency requiring inpatient treatment with
intravenous steroids. Approximately one-third of patients do not respond to steroids …